PSNL NASDAQ
Personalis, Inc.
1W: +0.0%
1M: -3.5%
3M: +33.7%
YTD: +102.3%
1Y: +68.0%
3Y: +1384.1%
5Y: -16.2%
$15.98
+0.10 (+0.63%)
After Hours: $15.72 (-0.26, -1.60%)
Weekly Expected Move ±2.0%
$15
$16
$16
$16
$16
Credit Risk of going bust: lower than 76% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Personalis, Inc. would be worth roughly what it owes.
Total debt $38.0M against a stock market value of $1.70B.
Distance to default 8.65 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $898K (short-term plus half of long-term), stock volatility 83.7%; Altman Z'' -2.16. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Personalis, Inc. would be worth roughly what it owes.
Total debt $38.0M against a stock market value of $1.70B.
Distance to default 8.65 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $898K (short-term plus half of long-term), stock volatility 83.7%; Altman Z'' -2.16. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-01-03
Earliest Filing
2025-07-09
Latest Filing
partner: 5
investor: 2
licensee: 1
customer: 1
Counterparties (Filed by PSNL)
9 relationshipsCompanies named in PSNL's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Tempus AI, Inc. | TEM | partner | Amendment to Commercialization and Reference Laboratory Agreement for NeXT Personal® marketing in colorectal cancer | 2025-07-09 | View |
| Merck Sharp & Dohme LLC | MRK | investor | Agreed to purchase 14,044,943 shares of Personalis, Inc. common stock for approximately $50.0 million. | 2024-12-19 | View |
| Tempus AI, Inc. | TEM | partner | Amended Commercialization and Reference Laboratory Agreement to market and sell Personalis' NeXT Personal test. | 2024-12-19 | View |
| ModernaTX, Inc. | MRNA | partner | Extended Statement of Work for ImmunoID NeXT Platform services and granted license options for intellectual property. | 2024-12-19 | View |
| Tempus AI, Inc. | TEM | investor | Invested in Personalis, Inc. via an investment agreement and exercised warrants to purchase common stock. | 2024-08-16 | View |
| Foresight Diagnostics, Inc. | — | licensee | Entered into a Settlement and License Agreement with Personalis, Inc. to settle litigation and receive a patent license. | 2024-06-27 | View |
| Tempus Labs, Inc. | — | partner | Partnered with Personalis, Inc. to market the NeXT Personal Dx assay in the US and perform development activities. | 2023-11-28 | View |
| U.S. Department of Veterans Affairs | — | customer | Contracted for whole genome sequencing services under the Million Veteran Program. | 2022-10-03 | View |
| BTIG, LLC | — | partner | Sales agent for at-the-market stock offering | 2022-01-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-06 | Other Events | View | |
| 2026-08-20 | Other Events | View | |
| 2026-08-04 | Earnings Release; Exhibits | View | |
| 2026-07-20 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-20 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-20 | Other Events | View | |
| 2026-05-13 | Other Events | View | |
| 2026-05-13 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-28 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-25 | Other Events | View | |
| 2025-11-10 | Other Events | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-22 | Other Events | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-09 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-05-19 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR